Piedmont Lithium Inc   (PLL)
Other Ticker:  

Piedmont Lithium Inc Segments

   7.63 % of total Revenue
   41.99 % of total Revenue
Total Life Sciences
   53.49 % of total Revenue
General Industrial
   19.67 % of total Revenue
   8.07 % of total Revenue
   11.6 % of total Revenue
Total Industrial
   46.51 % of total Revenue

Business Segments (May. 3. 2015)
(in millions $)
III. Quarter
(of total Revenues)
(May. 3. 2015)
(in millions $)
III. Quarter
(Profit Margin)
52.00 7.63 % 0.00 -
286.00 41.99 % 0.00 -
Total Life Sciences
364.32 53.49 % 93.91 25.78 %
General Industrial
134.00 19.67 % 0.00 -
55.00 8.07 % 0.00 -
79.00 11.6 % 0.00 -
Total Industrial
316.82 46.51 % 56.56 17.85 %
681.15 100 % 150.47 22.09 %

• View Income Statement • View Competition by Segment • View Annual Report

Growth rates by Segment (May. 3. 2015)
Y/Y Revenue
III. Quarter
Q/Q Revenue
(May. 3. 2015)
Y/Y Income
III. Quarter
Q/Q Income
-8.22 % -3.69 % - -
8.88 % 4.15 % - -
Total Life Sciences
3.14 % 1.64 % 3.36 % 5.66 %
General Industrial
-30.73 % -27.87 % - -
3.15 % -0.61 % - -
2.63 % 6.43 % - -
Total Industrial
-2.14 % 0.47 % 20.61 % 11.03 %
0.62 % 1.09 % 9.24 % 7.61 %

• View Growth rates • View Competitors Segment Growth • View Market Share

To get more information on Piedmont Lithium Inc 's Medical, BioPharmaceuticals, Total Life Sciences, General Industrial, Aerospace, Microelectronics, Total Industrial, Total segment. Select each division with the arrow.

  Piedmont Lithium Inc 's

Business Segments Description


During the first quarter of fiscal 2003, we reorganized the Life Sciences business to improve profitability. As a result, the hospital and medical OEM sub-segments, which were previously part of the BioPharmaceuticals segment, were combined with the Blood segment to create a new segment called Medical.


We sell disposable blood filtration and cardiovascular filtration products primarily to blood centers and hospitals. Our products are used to remove leukocytes (white blood cells) from blood used in transfusions and to filter out particulates, bacteria and viruses in the course of open-heart surgery, organ transplants, dialysis, intravenous feeding and breathing therapy. Leukocytes in donor blood can cause serious medical complications. Filtering out leukocytes reduces transfusion-related suppression of the immune system and helps protect against post-surgical infection. Based on medical risk and clinical benefits of filtration, hospitals and blood centers around the world have been converting to filtered blood. More than twenty countries either already are filtering all their donor blood or are moving toward this as a goal. In the United States, the Food and Drug Administration recommends blood filtration, and we believe that it is becoming the standard of care.


The BioPharmaceuticals segment includes sales of separation systems and disposable filters primarily to pharmaceutical, biotechnology and laboratory companies. We provide a broad range of advanced filtration solutions for each critical stage of drug development. Our product lines start in the laboratory with drug discovery, gene manipulation and proteomics applications. Our filtration systems and validation services allow drug manufacturers the quickest and surest path through the regulatory process and on to the market.

We believe that our established record of product performance and innovation is a particularly strong advantage among biopharmaceutical customers because of the high costs and safety risks associated with drug development and production.


We provide enabling and process enhancing technologies throughout the industrial marketplace. This includes the machinery and equipment, aerospace, microelectronics, municipal and industrial water, fuels, chemicals, energy, and food and beverage industries. We have the capability to provide customers with integrated solutions for all of their process fluids.


Included in this diverse segment are sales of filters, coalescers and separation systems for hydraulic, fuel and lubrication systems on mechanical equipment across many industries as well as to producers of oil, gas, electricity, chemicals, food and beverages, municipal and industrial water and paper. Virtually all of the raw materials, process fluids and waste streams that course through industry are candidates for multiple stages of filtration, separations and purification.

We believe that technologies that purify water for use and reuse represent an important opportunity. Governments around the world are implementing stringent new regulations governing drinking water standards and we believe that our filters and systems provide a solution for these requirements. With the acquisition of FSG, we increased our presence in the stable and growing food and beverage sector and we have enhanced our ability to better serve our other industrial markets.


The Aerospace segment includes sales of filtration and fluid monitoring equipment to the aerospace industry for use on commercial and military aircraft, including hydraulic, lubrication, and fuel filters, coalescers to remove water from fuel, filters to remove viruses from aircraft cabin air and filter monitoring systems. Our products and systems are also used in ships and land-based military vehicles.

The Company believes that performance and quality of product and service, as well as price, are determinative in most sales.


Included in this segment are sales of disposable filtration products to producers of semiconductors, computer terminals, fiber optics, disk drives, thin film rigid discs and photographic film. The drive to shrink the size of computer components requires increasingly finer levels of filtration and purification, sometimes down to the level of parts per trillion. From the raw materials of silicon and water to the gases and chemicals of chip manufacture, we have extensive engineered solutions for the needs of this demanding industry.

Our products are sold to customers in this segment through our own personnel, distributors and manufacturers’ representatives.


Sales by Geography Competition By Business Segments Company Profile

Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

SURG's Profile

Stock Price

SURG's Financials

Business Description


Charts & Quotes

SURG's News


SURG's Competitors

Customers & Markets

Economic Indicators

SURG's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries






About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071